UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Unpack the common reasons budgeting is hard and learn approachable methods to develop healthier financial habits.
24,094 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Apple posted a record iPhone revenue quarter and strong customer satisfaction, yet the market remains divided on how ...
Alphabet stands at a crossroads: Sundar Pichai could pull in up to $692 million over three years, but half of that de...
AST SpaceMobile and Globalstar chart divergent paths toward 2026 as they push new revenue streams and cash flow.
As Alphabet shifts its advertising footprint and data strategy, Disney investors just really need to understand the p...
Jim Cramer spotlights a surprising quarter from Marvell, arguing the company’s data center-focused growth could redef...
As mortgage rates shift and originations evolve, loandepot (LDI) 2025 earnings will hinge on rate flow, loan mix, and...
Lumentum says its backlog extends through 2027, signaling a sustained AI-driven demand boom for optical components. N...
Strategy's STRC instrument posted a record single-day volume, funding a large BTC purchase as corporate crypto treasu...
The Ethereum Foundation has quietly moved 5,000 ETH to BitMine in a $10 million over-the-counter trade, marking its s...
Six senators blocked a key procedural step in advancing a CBDC ban within a broad housing and banking package, a move...
Tilray Brands is expanding beyond its cannabis roots into beverages and other segments. This article examines whether...